Kura Oncology (KURA)

Kura Oncology (KURA) Stock Price & Analysis


KURA Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$10.30 - $19.93
Previous Close$12.03
Average Volume (3M)649.50K
Market Cap
Enterprise Value$399.36M
Total Cash (Recent Filing)$437.99M
Total Debt (Recent Filing)$14.02M
Price to Earnings (P/E)-5.9
May 09, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.03
Shares Outstanding68,300,000
10 Day Avg. Volume470,947
30 Day Avg. Volume649,504
Standard Deviation0.16
Financial Highlights & Ratios
Price to Book (P/B)2.00
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio-10.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-2.96
Price Target Upside164.38% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering9



Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Kura Oncology’s price range in the past 12 months?
Kura Oncology lowest stock price was $10.30 and its highest was $19.93 in the past 12 months.
    What is Kura Oncology’s market cap?
    Currently, no data Available
    When is Kura Oncology’s upcoming earnings report date?
    Kura Oncology’s upcoming earnings report date is May 09, 2023 which is in 46 days.
      How were Kura Oncology’s earnings last quarter?
      Kura Oncology released its earnings results on Feb 23, 2023. The company reported -$0.49 earnings per share for the quarter, beating the consensus estimate of -$0.572 by $0.082.
        Is Kura Oncology overvalued?
        According to Wall Street analysts Kura Oncology’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Kura Oncology pay dividends?
          Kura Oncology does not currently pay dividends.
          What is Kura Oncology’s EPS estimate?
          Kura Oncology’s EPS estimate is -$0.54.
            How many shares outstanding does Kura Oncology have?
            Kura Oncology has 68,438,576 shares outstanding.
              What happened to Kura Oncology’s price movement after its last earnings report?
              Kura Oncology reported an EPS of -$0.49 in its last earnings report, beating expectations of -$0.572. Following the earnings report the stock price went down -2.743%.
                Which hedge fund is a major shareholder of Kura Oncology?
                Among the largest hedge funds holding Kura Oncology’s share is Deerfield Management Company, LP. It holds Kura Oncology’s shares valued at 30M.


                  Kura Oncology Stock Smart Score

                  The Kura Oncology stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  Kura Oncology

                  Kura Oncology, Inc. operates as a clinical-stage biopharmaceutical company which engages in the research and development of medicines for the treatment of cancer. Its pipeline includes Tipifarnib which is a Farnesyl transferase inhibitor for HRAS Mutant Solid Tumors, Chronic Myelomonocytic Leukemia; KO-947 which is an ERK inhibitor for MAPK Pathway Tumors; and KO-539 which is a Menin MLL inhibitor for acute leukemias. The company was founded by Troy E. Wilson, Yi Liu, Pingda Ren and Antonio Gualberto on August 22, 2014 and is headquartered in La Jolla, CA.


                  Top 5 ETFs holding KURA

                  Market Value
                  Smart Score
                  Fidelity Nasdaq Composite Index ETF
                  Dimensional U.S. Equity ETF
                  Up to five ETFs with an Outperform Smart Score that hold KURA. The ETFs are listed according to market value of KURA within the ETF


                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  Deciphera Pharmaceuticals
                  Biohaven Ltd.
                  Arcutis Biotherapeutics
                  Morphic Holding
                  Lyell Immunopharma

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis